What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Gene
- Cancer
Her scientific interests lie mostly in Immunology, Hemophagocytic lymphohistiocytosis, Internal medicine, Transplantation and Gastroenterology.
The various areas that Alexandra H. Filipovich examines in her Immunology study include Cytotoxic T cell and Eosinophilic esophagitis.
Her Hemophagocytic lymphohistiocytosis research incorporates themes from Alemtuzumab, Pediatrics, Familial Hemophagocytic Lymphohistiocytosis and Intensive care medicine.
Her study looks at the intersection of Internal medicine and topics like Oncology with Long term results.
Her Transplantation research incorporates elements of Leukemia and Severe combined immunodeficiency.
Alexandra H. Filipovich studied Gastroenterology and Surgery that intersect with Cerebrospinal fluid and Meningoencephalitis.
Her most cited work include:
- HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. (2671 citations)
- Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. (697 citations)
- Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. (597 citations)
What are the main themes of her work throughout her whole career to date?
Alexandra H. Filipovich mostly deals with Immunology, Internal medicine, Transplantation, Hemophagocytic lymphohistiocytosis and Hematopoietic stem cell transplantation.
Her biological study deals with issues like Cytotoxic T cell, which deal with fields such as CD8.
Alexandra H. Filipovich has researched Internal medicine in several fields, including Gastroenterology, Surgery and Oncology.
Her Transplantation study incorporates themes from Hematopoietic cell, Regimen, Stem cell and Bone marrow.
Her research investigates the connection between Hemophagocytic lymphohistiocytosis and topics such as Familial Hemophagocytic Lymphohistiocytosis that intersect with problems in UNC13D and Hepatosplenomegaly.
In her work, Newborn screening and Genetic enhancement is strongly intertwined with Severe combined immunodeficiency, which is a subfield of Hematopoietic stem cell transplantation.
She most often published in these fields:
- Immunology (53.16%)
- Internal medicine (29.54%)
- Transplantation (25.32%)
What were the highlights of her more recent work (between 2013-2020)?
- Immunology (53.16%)
- Internal medicine (29.54%)
- Hematopoietic stem cell transplantation (21.94%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Immunology, Internal medicine, Hematopoietic stem cell transplantation, Transplantation and Hemophagocytic lymphohistiocytosis.
The study of Immunology is intertwined with the study of Treatment outcome in a number of ways.
Her biological study spans a wide range of topics, including Gastroenterology and Oncology.
Her Hematopoietic stem cell transplantation study is concerned with the larger field of Surgery.
Her Transplantation research integrates issues from Hematopoietic cell, Immunodeficiency, Young adult, MECOM and Stem cell.
Her Hemophagocytic lymphohistiocytosis research includes themes of Dermatology, Cytotoxic T cell and Familial Hemophagocytic Lymphohistiocytosis.
Between 2013 and 2020, her most popular works were:
- Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009 (389 citations)
- Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy (349 citations)
- A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency (262 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Alexandra H. Filipovich spends much of her time researching Immunology, Transplantation, Internal medicine, Hematopoietic stem cell transplantation and Hemophagocytic lymphohistiocytosis.
Her Immunology research focuses on Familial Hemophagocytic Lymphohistiocytosis, Immune system, Immune receptor, Abatacept and Immune dysregulation.
Alexandra H. Filipovich usually deals with Transplantation and limits it to topics linked to Severe combined immunodeficiency and Natural history and Virology.
Her study in Internal medicine is interdisciplinary in nature, drawing from both Surgery and Oncology.
Her Hematopoietic stem cell transplantation study integrates concerns from other disciplines, such as Infectious disease, Transplantation Conditioning, Pediatrics and Immunodeficiency.
Her Hemophagocytic lymphohistiocytosis research is multidisciplinary, incorporating perspectives in Cytotoxic T cell, Pathogenesis, Treatment outcome, Interleukin and UNC13D.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
